257 related articles for article (PubMed ID: 24862669)
21. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Raue F; Frank-Raue K
Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
[TBL] [Abstract][Full Text] [Related]
22. Follicular lesions of the thyroid.
Mathur A; Olson MT; Zeiger MA
Surg Clin North Am; 2014 Jun; 94(3):499-513. PubMed ID: 24857573
[TBL] [Abstract][Full Text] [Related]
23. Survivin expression is significantly linked to the dedifferentiation of thyroid carcinoma.
Ito Y; Yoshida H; Uruno T; Nakano K; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
Oncol Rep; 2003; 10(5):1337-40. PubMed ID: 12883703
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and management of differentiated thyroid cancer using molecular biology.
Witt RL; Ferris RL; Pribitkin EA; Sherman SI; Steward DL; Nikiforov YE
Laryngoscope; 2013 Apr; 123(4):1059-64. PubMed ID: 23404751
[TBL] [Abstract][Full Text] [Related]
25. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
[TBL] [Abstract][Full Text] [Related]
26. Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.
Batista FA; Ward LS; Marcello MA; Martins MB; Peres KC; Torricelli C; Bufalo NE; Soares FA; da Silva MJ; Assumpção LV
J Endocrinol Invest; 2016 Apr; 39(4):423-9. PubMed ID: 26370671
[TBL] [Abstract][Full Text] [Related]
27. Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma.
Wiseman SM; Griffith OL; Deen S; Rajput A; Masoudi H; Gilks B; Goldstein L; Gown A; Jones SJ
Arch Surg; 2007 Aug; 142(8):717-27; discussion 727-9. PubMed ID: 17709725
[TBL] [Abstract][Full Text] [Related]
28. Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions.
Albores-Saavedra J; Hernandez M; Sanchez-Sosa S; Simpson K; Angeles A; Henson DE
Am J Surg Pathol; 2007 May; 31(5):729-36. PubMed ID: 17460457
[TBL] [Abstract][Full Text] [Related]
29. Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls.
Lacoste-Collin L; d'Aure D; Bérard E; Rouquette I; Delisle MB; Courtade-Saïdi M
Cytopathology; 2014 Jun; 25(3):160-9. PubMed ID: 24460983
[TBL] [Abstract][Full Text] [Related]
30. Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression.
Rosignolo F; Maggisano V; Sponziello M; Celano M; Di Gioia CR; D'Agostino M; Giacomelli L; Verrienti A; Dima M; Pecce V; Durante C
J Endocrinol Invest; 2015 Dec; 38(12):1283-9. PubMed ID: 26003825
[TBL] [Abstract][Full Text] [Related]
31. Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases.
Belfiore A; Gangemi P; Costantino A; Russo G; Santonocito GM; Ippolito O; Di Renzo MF; Comoglio P; Fiumara A; Vigneri R
J Clin Endocrinol Metab; 1997 Jul; 82(7):2322-8. PubMed ID: 9215314
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of human tumor-associated antigen, RCAS1, is significantly linked to dedifferentiation of thyroid carcinoma.
Ito Y; Yoshida H; Nakano K; Kobayashi K; Yokozawa T; Hirai K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Oncology; 2003; 64(1):83-9. PubMed ID: 12457035
[TBL] [Abstract][Full Text] [Related]
33. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
[TBL] [Abstract][Full Text] [Related]
34. Unusual tumors of the thyroid gland.
Baloch ZW; LiVolsi VA
Endocrinol Metab Clin North Am; 2008 Jun; 37(2):297-310, vii. PubMed ID: 18502328
[TBL] [Abstract][Full Text] [Related]
35. Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009.
Ceresini G; Corcione L; Michiara M; Sgargi P; Teresi G; Gilli A; Usberti E; Silini E; Ceda GP
Cancer; 2012 Nov; 118(22):5473-80. PubMed ID: 22517468
[TBL] [Abstract][Full Text] [Related]
36. Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC).
Gillanders SL; O'Neill JP
Eur J Surg Oncol; 2018 Mar; 44(3):286-296. PubMed ID: 28801060
[TBL] [Abstract][Full Text] [Related]
37. Advances in the follow-up of differentiated or medullary thyroid cancer.
Elisei R; Pinchera A
Nat Rev Endocrinol; 2012 Apr; 8(8):466-75. PubMed ID: 22473335
[TBL] [Abstract][Full Text] [Related]
38. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
39. Thyroid carcinoma producing β-human chorionic gonadotropin shows different clinical behavior.
Gu H; Sui S; Cui X; Han B; Zhang C; Qi M; Li C; Liu Z
Pathol Int; 2018 Apr; 68(4):207-213. PubMed ID: 29446856
[TBL] [Abstract][Full Text] [Related]
40. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]